Telbivudine for the treatment of chronic hepatitis B

Hepatitis B - telbivudine: review decision - October 2011 information

Appendix A: decision paper presented to the Institute's Guidance Executive (PDF 106 KB)

Hepatitis B - telbivudine: review proposal - July 2011 information

Appendix A: provisional matrix of stakeholders (PDF 74 KB)

Appendix B: proposal paper presented to the Institute's Guidance Executive (PDF 138 KB)

Review decision: June 2009 information

Appendix 1: Proposal comment summary table (PDF 28 KB)

Review proposal: May 2009 information

Review proposal: May 2009, Appendix A - Provisional matrix (PDF 37 KB)

Hepatitis B - telbivudine: final appraisal determination 

Hepatitis B - telbivudine: final appraisal determination information

Hepatitis B - telbivudine: final appraisal determination (PDF 94 KB)

Consultee and commentator comments on the ACD

Southampton Health Technology Assessment Group (PDF 15 KB)

Department of Health (PDF 12 KB)

Bury Primary Care Trust (PDF 12 KB)

Royal College of Physicians (PDF 27 KB)

Royal College of Nursing (PDF 19 KB)

British Infection Society (PDF 17 KB)

Novartis Pharmaceuticals - appendix A (PDF 526 KB)

Novartis Pharmaceuticals (PDF 201 KB)

Expert comments on the ACD

Ms Penny Wilson Webb (PDF 45 KB)

Professor Howard Thomas (PDF 15 KB)

Table of comments on the ACD (PDF 219 KB)

Hepatitis B - telbivudine: Appraisal consultation document 

Evaluation report

Non-manufacturer submissions

Royal College of Physicians (PDF 90 KB)

Royal College of Pathologists (PDF 38 KB)

Novartis Pharmaceuticals UK Ltd (PDF 567 KB)

Expert written personal statements

Wilson Webb (PDF 39 KB)

Thomas (PDF 35 KB)

Dusheiko (PDF 41 KB)

Boxall (PDF 36 KB)

Hepatitis B - telbivudine: evidence review group report (PDF 1.11 MB)

Pre-meeting briefing (PDF 162 KB)

Hepatitis B - Telbivudine: appraisal consultation document information

Stakeholder list: final matrix (PDF 42 KB)

Draft scope pre referral (PDF 35 KB)

Provisional matrix pre referral (PDF 38 KB)

Comments on the matrix (PDF 100 KB)

Comments on the scope (PDF 110 KB)

Comments on the scope (PDF 110 KB)